Skip to main content
. 2020 Jul 11;215:107627. doi: 10.1016/j.pharmthera.2020.107627

Table 1.

Upregulated acute-phase proteins used as inflammatory biomarkers.

Acute phase protein Main role Normal range Time after inflammatory stimulus (in hours) Maximum fold change in plasma concentration
CRP (C-reactive protein) Binding to pathogens and damaged cells, opsonin, complement activation < 0.5 mg/L 6-12 h x 1000
PCT (procalcitonin) Unknown < 10 pg/mL 6- 8 h x 400-1000
SAA (Serum amyloid A) Opsonin, regulation of innate defense, induction of extracellular matrix degrading enzymes, chemoattractant, apolipoprotein with HDL, regulation of lipid metabolism < 10 mg/L 6-12 h x 1000
α1-glycoprotein (or orosomucoid) Binding of plasma proteins and mediators, chaperone, regulation of innate defense < 1.5 g/L 12 h x 2-4
Haptoglobin Scavenging of hemoglobin, antioxidants, angiogenesis, chaperone 0.5-2 g/L 12 h x 2-4
Fibrinogen Clot formation 2-4 g/L 12 h x 2-4
AAT (α1-anti trypsin) Enzyme inhibition 2-4 g/L 12 h x 2-4
C3 complement Pathogen recognition, destruction, chemotaxis, opsonin, vasoregulation 0.8 à 18 g/L 48 h x 1.5
Ceruloplasmin Iron and copper homeostasis 0.2-0.6 g/L 48 h x 1.5